Free Trial

StockNews.com Initiates Coverage on Veradigm (NASDAQ:MDRX)

Veradigm logo with Business Services background

StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX - Free Report) in a research report report published on Thursday morning. The brokerage issued a hold rating on the software maker's stock.

Veradigm Stock Performance

Shares of NASDAQ MDRX traded down $0.24 during midday trading on Thursday, hitting $9.51. The stock had a trading volume of 22,207 shares, compared to its average volume of 1,480,760. The company has a fifty day moving average price of $9.98 and a 200 day moving average price of $9.73. Veradigm has a 1-year low of $5.01 and a 1-year high of $11.80.

Institutional Trading of Veradigm

A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new position in shares of Veradigm Inc. (NASDAQ:MDRX - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 3,974 shares of the software maker's stock, valued at approximately $38,000.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Read More

→ Has Trump Finally Gone Too Far? (From Insiders Exposed) (Ad)

Should you invest $1,000 in Veradigm right now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Energy Stocks Are Poised for Explosive Growth in 2025
From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines